Sponsored Links

BRIEF-Scancell updates on clinical trial

Related Topics

LONDON | Tue Jan 29, 2013 2:25am EST

LONDON Jan 29 (Reuters) - Scancell Holdings PLC : * update on patient recruitment in clinical trial * treats final patient in the second part of its Phase 1/2 clinical trial of SCIB1,its DNA ImmunoBody vaccine being developed for the treatment of melanoma.
Healthcare
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.